An Guo Huang
Director/Board Member presso Shenzhen Xinnuo Health Industry Investment Co., Ltd.
Profilo
An Guo Huang is on the board of Shenzhen Xinnuo Health Industry Investment Co., Ltd.
In the past he held the position of Chief Financial Officer & Board Secretary at Sinocare, Inc.
Mr. Huang received an undergraduate degree from Hunan Normal University, a graduate degree from Hunan University and an MBA from Central South University.
Posizioni attive di An Guo Huang
Società | Posizione | Inizio |
---|---|---|
Shenzhen Xinnuo Health Industry Investment Co., Ltd.
Shenzhen Xinnuo Health Industry Investment Co., Ltd. Financial ConglomeratesFinance Shenzhen Xinnuo Health Industry Investment Co. Ltd. engages in the provision of investment services with interests in medical and health industries. Its business activities include investment in biotechnology, biotechnology research and development, health management and consulting, and investment management and advisory services. The company was founded on April 27, 2015 and is headquartered in Shenzhen, China. | Director/Board Member | - |
Precedenti posizioni note di An Guo Huang
Società | Posizione | Fine |
---|---|---|
SINOCARE INC. | Director of Finance/CFO | 29/12/2023 |
Formazione di An Guo Huang
Hunan Normal University | Undergraduate Degree |
Hunan University | Graduate Degree |
Central South University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SINOCARE INC. | Health Technology |
Aziende private | 1 |
---|---|
Shenzhen Xinnuo Health Industry Investment Co., Ltd.
Shenzhen Xinnuo Health Industry Investment Co., Ltd. Financial ConglomeratesFinance Shenzhen Xinnuo Health Industry Investment Co. Ltd. engages in the provision of investment services with interests in medical and health industries. Its business activities include investment in biotechnology, biotechnology research and development, health management and consulting, and investment management and advisory services. The company was founded on April 27, 2015 and is headquartered in Shenzhen, China. | Finance |